FIELD: organic chemistry, medicine, pharmacy, pharmacotherapy.
SUBSTANCE: method involves administration in mammal the effective dose of 6-hydroxy-8-[4[4-(2-pyrimidinyl)piperazinyl]butyl]-8-azaspiro[4,5]-7,9-dione or its pharmaceutically acceptable salt of acid addition or its hydrate. Method expands arsenal of medicinal agents used for suppression of fear sensation.
EFFECT: valuable properties of agent.
3 tbl, 6 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PATIENTS WITH ROSACEA | 2022 |
|
RU2793793C1 |
| METHOD OF TREATING CHRONIC DERMATOSES | 2018 |
|
RU2709534C1 |
| IDENTIFICATION OF PATIENTS' REACTION TO ADMINISTRATION OF S1P RECEPTOR MODULATOR | 2013 |
|
RU2785736C2 |
| USING BIOACTIVE HEPIRONE METABOLITES | 2000 |
|
RU2282448C2 |
| METHOD FOR CARRYING OUT PREMEDICATION IN PATIENTS DISTINGUISHED BY PREDOMINATING STHENIC PERSONALITY TRAITS UNDER STRESS CONDITIONS WHEN SUBJECTED TO OUTPATIENT DENTISTRY INTERVENTION | 2005 |
|
RU2283103C1 |
| USE OF BUSPIRONE FOR THE TREATMENT OF FUNCTIONAL DIZZINESS | 2017 |
|
RU2660583C1 |
| N-OXIDES AS PRODRUG OF PIPERAZINE AND PIPERIDINE DERIVATIVES | 2006 |
|
RU2394821C2 |
| PHARMACEUTICAL COMBINATION FOR TREATING AND/OR PREVENTING DISORDERS RELATED TO OVERWEIGHT AND/OR OBESITY, AND BASED METHOD OF TREATING | 2014 |
|
RU2552926C1 |
| COMBINATION FOR PREVENTION, CORRECTION AND THERAPY OF PAIN RELATED TO NEURODEGENERATION OR ASSOCIATED WITH SOMATOFORM DISORDERS | 2013 |
|
RU2506077C1 |
| METHOD, MEDICINAL FORMULATION AND SETS FOR ENHANCING ORAL BIOLOGICAL AVAILABILITY OF PHARMACEUTICAL AGENTS | 2003 |
|
RU2296561C2 |
